Previous close | 6.73 |
Open | 6.69 |
Bid | 6.68 x 200 |
Ask | 6.71 x 200 |
Day's range | 6.59 - 6.74 |
52-week range | 4.14 - 9.37 |
Volume | |
Avg. volume | 1,344,446 |
Market cap | 2.643B |
Beta (5Y monthly) | 1.43 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.02 |
Earnings date | 09 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.76 |
Here is how GoodRx Holdings, Inc. (GDRX) and Amplifon S.p.A. (AMFPF) have performed compared to their sector so far this year.
SANTA MONICA, Calif., April 11, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.
ELV vs. GDRX: Which Stock Is the Better Value Option?